Cinaxadamtase alfa
As of the edition of 20 October 2026, Cinaxadamtase alfa is an enzyme: marketed, first approved in 2024 (JP); acts on VWF.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2024
- Kind
- Enzyme
- Brand name
- Adzynma
- First approved
- 26 March 2024 (JP)
- Approvals on record
- 2 in 1 region
- Holder of the most recent approval
- Takeda
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| VWF | von Willebrand factor | P04275 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Takeda | Applicant | 2024 to now |